![CA19–9 decrease and survival according to platelet level in patients with advanced pancreatic cancer | BMC Cancer | Full Text CA19–9 decrease and survival according to platelet level in patients with advanced pancreatic cancer | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-019-6078-2/MediaObjects/12885_2019_6078_Fig1_HTML.png)
CA19–9 decrease and survival according to platelet level in patients with advanced pancreatic cancer | BMC Cancer | Full Text
![Blood sample for cancer marker including CA 125, CA 15.3, CA 19.9, AFP and CEA test with laboratory report. Tumor marker test. 8930994 Stock Photo at Vecteezy Blood sample for cancer marker including CA 125, CA 15.3, CA 19.9, AFP and CEA test with laboratory report. Tumor marker test. 8930994 Stock Photo at Vecteezy](https://static.vecteezy.com/system/resources/previews/008/930/994/large_2x/blood-sample-for-cancer-marker-including-ca-125-ca-15-3-ca-19-9-afp-and-cea-test-with-laboratory-report-tumor-marker-test-photo.jpg)
Blood sample for cancer marker including CA 125, CA 15.3, CA 19.9, AFP and CEA test with laboratory report. Tumor marker test. 8930994 Stock Photo at Vecteezy
![Patients with normal‑range CA19‑9 levels represent a distinct subgroup of pancreatic cancer patients Patients with normal‑range CA19‑9 levels represent a distinct subgroup of pancreatic cancer patients](https://www.spandidos-publications.com/article_images/ol/13/2/ol-13-02-0881-g00.jpg)
Patients with normal‑range CA19‑9 levels represent a distinct subgroup of pancreatic cancer patients
![Premium Photo | Blood sample with abnormal ca 19 9 report or tumor marker test for pancreatic cancer Premium Photo | Blood sample with abnormal ca 19 9 report or tumor marker test for pancreatic cancer](https://img.freepik.com/premium-photo/blood-sample-with-abnormal-ca-19-9-report-tumor-marker-test-pancreatic-cancer_595440-716.jpg)
Premium Photo | Blood sample with abnormal ca 19 9 report or tumor marker test for pancreatic cancer
![Cureus | Low Carbohydrate Antigen 19-9 (CA 19-9) Levels in a Patient Highly Suspected of Having Caput Pancreas Tumor | Article Cureus | Low Carbohydrate Antigen 19-9 (CA 19-9) Levels in a Patient Highly Suspected of Having Caput Pancreas Tumor | Article](https://assets.cureus.com/uploads/figure/file/360044/lightbox_ee05f1a0c0c511ecb401afcf8e44f72b-IHBD-and-EHBD.png)
Cureus | Low Carbohydrate Antigen 19-9 (CA 19-9) Levels in a Patient Highly Suspected of Having Caput Pancreas Tumor | Article
![Tumor marker CA 19.9 and CEA studies, with TNM staging at presentation | Download Scientific Diagram Tumor marker CA 19.9 and CEA studies, with TNM staging at presentation | Download Scientific Diagram](https://www.researchgate.net/publication/342853002/figure/tbl2/AS:911956965851136@1594438892266/Tumor-marker-CA-199-and-CEA-studies-with-TNM-staging-at-presentation.png)
Tumor marker CA 19.9 and CEA studies, with TNM staging at presentation | Download Scientific Diagram
![Table 2 from Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as Tumor Markers in Patients with Lung Cancer: Comparison with CYFRA 21-1, CEA, SCC and NSE | Semantic Scholar Table 2 from Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as Tumor Markers in Patients with Lung Cancer: Comparison with CYFRA 21-1, CEA, SCC and NSE | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8ca3c249142cbe1d4e92eefae11e9bfcb042c18c/3-Table2-1.png)
Table 2 from Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as Tumor Markers in Patients with Lung Cancer: Comparison with CYFRA 21-1, CEA, SCC and NSE | Semantic Scholar
![Cancers | Free Full-Text | Complementary Use of Carbohydrate Antigens Lewis a, Lewis b, and Sialyl-Lewis a (CA19.9 Epitope) in Gastrointestinal Cancers: Biological Rationale towards a Personalized Clinical Application Cancers | Free Full-Text | Complementary Use of Carbohydrate Antigens Lewis a, Lewis b, and Sialyl-Lewis a (CA19.9 Epitope) in Gastrointestinal Cancers: Biological Rationale towards a Personalized Clinical Application](https://pub.mdpi-res.com/cancers/cancers-12-01509/article_deploy/html/images/cancers-12-01509-g002.png?1592549386)
Cancers | Free Full-Text | Complementary Use of Carbohydrate Antigens Lewis a, Lewis b, and Sialyl-Lewis a (CA19.9 Epitope) in Gastrointestinal Cancers: Biological Rationale towards a Personalized Clinical Application
![Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies](http://www.tropicalgastro.com/uploads/Untitlnkged-30.jpg)